Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.77M | 1.30M | 1.10M | 1.03M | 700.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.77M | 1.30M | 1.10M | 1.03M | 700.20K |
| Cost of Revenue | 599.00K | 452.40K | 408.50K | 406.70K | 159.40K |
| Gross Profit | 1.17M | 849.70K | 688.40K | 625.40K | 540.90K |
| SG&A Expenses | 1.34M | 1.30M | 1.27M | 1.17M | 1.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.94M | 1.75M | 1.68M | 1.57M | 1.35M |
| Operating Income | -166.60K | -446.50K | -579.30K | -540.10K | -652.00K |
| Income Before Tax | -277.60K | -618.50K | -578.50K | -537.90K | -649.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -277.60K | -618.50K | -578.50K | -537.90K | -649.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -277.60K | -618.50K | -578.50K | -537.90K | -649.70K |
| EBIT | -166.60K | -446.50K | -579.30K | -540.10K | -652.00K |
| EBITDA | -140.40K | -424.20K | -555.40K | -517.00K | -629.00K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 48.41M | 48.29M | 48.06M | 47.54M | 46.82M |
| Average Diluted Shares Outstanding | 48.41M | 48.29M | 48.06M | 47.54M | 46.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |